CN101641341A - 酰胺化合物及其作为抗肿瘤剂的用途 - Google Patents
酰胺化合物及其作为抗肿瘤剂的用途 Download PDFInfo
- Publication number
- CN101641341A CN101641341A CN200880008093A CN200880008093A CN101641341A CN 101641341 A CN101641341 A CN 101641341A CN 200880008093 A CN200880008093 A CN 200880008093A CN 200880008093 A CN200880008093 A CN 200880008093A CN 101641341 A CN101641341 A CN 101641341A
- Authority
- CN
- China
- Prior art keywords
- nmr
- cdcl
- mmol
- alkyl
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/02—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/01—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07104071 | 2007-03-13 | ||
| EP07104071.1 | 2007-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101641341A true CN101641341A (zh) | 2010-02-03 |
Family
ID=39535770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880008093A Pending CN101641341A (zh) | 2007-03-13 | 2008-03-12 | 酰胺化合物及其作为抗肿瘤剂的用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20100113504A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2137169A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2010520915A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20100014974A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101641341A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2008225833A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0809000A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2677874A1 (cg-RX-API-DMAC7.html) |
| EA (1) | EA200970848A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL200188A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2009009374A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2008110583A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200907077B (cg-RX-API-DMAC7.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109516926A (zh) * | 2018-07-27 | 2019-03-26 | 四川大学 | 一种荜茇明碱衍生物的制备与抗肿瘤活性 |
| CN120924186A (zh) * | 2025-10-14 | 2025-11-11 | 长沙市芯星新能源科技有限公司 | 负极粘结剂、锂离子电池负极及其制备方法 |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2230227A1 (en) * | 2009-03-20 | 2010-09-22 | Bracco Imaging S.p.A | Process for the preparation of triiodinated carboxylic aromatic derivatives |
| JP2013508323A (ja) * | 2009-10-21 | 2013-03-07 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | 合成大環状アミドhdac6阻害剤化合物およびそれらの治療剤としての用途 |
| EP3941457B1 (en) * | 2019-03-21 | 2026-01-21 | Merck Sharp & Dohme LLC | Inhibitors of histone deacetylase useful for the treatment or prevention of hiv infection |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0014254A (pt) * | 1999-09-08 | 2002-08-27 | Sloan Kettering Inst Cancer | Nova classe de agentes de citodiferenciação e inibidores de desacetilase de histona, e métodos de uso dos mesmos |
| AU2006228957A1 (en) * | 2005-04-01 | 2006-10-05 | Methylgene Inc. | Inhibitors of histone deacetylase |
-
2008
- 2008-03-12 CA CA002677874A patent/CA2677874A1/en not_active Abandoned
- 2008-03-12 KR KR1020097018936A patent/KR20100014974A/ko not_active Withdrawn
- 2008-03-12 MX MX2009009374A patent/MX2009009374A/es not_active Application Discontinuation
- 2008-03-12 JP JP2009553140A patent/JP2010520915A/ja not_active Withdrawn
- 2008-03-12 EA EA200970848A patent/EA200970848A1/ru unknown
- 2008-03-12 BR BRPI0809000-9A2A patent/BRPI0809000A2/pt not_active IP Right Cessation
- 2008-03-12 AU AU2008225833A patent/AU2008225833A1/en not_active Abandoned
- 2008-03-12 CN CN200880008093A patent/CN101641341A/zh active Pending
- 2008-03-12 WO PCT/EP2008/052965 patent/WO2008110583A1/en not_active Ceased
- 2008-03-12 EP EP08717710A patent/EP2137169A1/en not_active Withdrawn
- 2008-03-12 US US12/528,912 patent/US20100113504A1/en not_active Abandoned
-
2009
- 2009-07-30 IL IL200188A patent/IL200188A0/en unknown
- 2009-10-12 ZA ZA200907077A patent/ZA200907077B/xx unknown
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109516926A (zh) * | 2018-07-27 | 2019-03-26 | 四川大学 | 一种荜茇明碱衍生物的制备与抗肿瘤活性 |
| CN109516926B (zh) * | 2018-07-27 | 2021-09-17 | 四川大学 | 一种荜茇明碱衍生物制备及用途 |
| CN120924186A (zh) * | 2025-10-14 | 2025-11-11 | 长沙市芯星新能源科技有限公司 | 负极粘结剂、锂离子电池负极及其制备方法 |
| CN120924186B (zh) * | 2025-10-14 | 2025-12-23 | 长沙市芯星新能源科技有限公司 | 负极粘结剂、锂离子电池负极及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20100113504A1 (en) | 2010-05-06 |
| WO2008110583A1 (en) | 2008-09-18 |
| AU2008225833A1 (en) | 2008-09-18 |
| IL200188A0 (en) | 2010-04-15 |
| KR20100014974A (ko) | 2010-02-11 |
| CA2677874A1 (en) | 2008-09-18 |
| ZA200907077B (en) | 2010-07-28 |
| JP2010520915A (ja) | 2010-06-17 |
| MX2009009374A (es) | 2009-09-21 |
| EP2137169A1 (en) | 2009-12-30 |
| BRPI0809000A2 (pt) | 2014-11-11 |
| EA200970848A1 (ru) | 2010-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6790094B2 (ja) | イオンチャネル阻害化合物、医薬製剤および使用 | |
| JP7042468B2 (ja) | Magl阻害剤 | |
| RU2293727C2 (ru) | Амиды антраниловой кислоты с гетероарилсульфонильной боковой цепью и содержащие их фармацевтические композиции | |
| JP4721087B2 (ja) | トリアザスピロ[5.5]ウンデカン誘導体およびそれらを有効成分とする薬剤 | |
| JP6138243B2 (ja) | 置換ピペリジノアセトアミドおよびその使用 | |
| PH12014501162B1 (en) | Aryl dihydropyridinone and piperidinone as mgat2 inhibitors | |
| WO2018110669A1 (en) | Activator of trek (twik related k+ channels) channels | |
| CN113429387B (zh) | 一种苯并[b]硒吩类STING调控剂、其制备方法及用途 | |
| JP7134177B2 (ja) | 大環状広域抗生物質 | |
| EP3114121A1 (en) | Dihydropyridinone mgat2 inhibitors for use in the treatment of metabolic disorders | |
| EP2760830A1 (en) | Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors | |
| CN113614095A (zh) | 作为精氨酸酶抑制剂的烷基硼酸类化合物 | |
| CN118290322A (zh) | 用于治疗病态状况的芳香型分子 | |
| TW200524578A (en) | Protease inhibitors | |
| JP7726591B2 (ja) | ボロン酸化合物 | |
| JP2022550489A (ja) | スルホ置換ビアリール化合物又はその塩並びにその調製方法及び使用 | |
| JP2010520915A (ja) | アミド化合物および抗腫瘍剤としてのその使用 | |
| CN102066345B (zh) | *唑烷衍生物作为nmda拮抗剂 | |
| JPWO2003064422A1 (ja) | イミダゾ[1,2−a]ピリジン誘導体 | |
| TWI659022B (zh) | 作為d-胺基酸氧化酶(daao)抑制劑之新穎經取代苯并咪唑衍生物 | |
| TW201821404A (zh) | 作為ROR γ調節劑之三環碸 | |
| HK1140477A (en) | Amide compounds and their use as antitumor agents | |
| CN117242061A (zh) | 用于治疗艰难梭菌的二氮杂卓衍生物 | |
| IT202100011237A1 (it) | Composti inibitori dell’inflammasoma nlrp3 e loro uso | |
| KR20010083109A (ko) | 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1140477 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20100203 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1140477 Country of ref document: HK |